- Home
- HTHT vs ASND Comparison
HTHT vs ASND Comparison
Compare HTHT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTHT
- ASND
- Stock Information
- Founded
- HTHT 2005
- ASND 2006
- Country
- HTHT China
- ASND Denmark
- Employees
- HTHT N/A
- ASND N/A
- Industry
- HTHT Hotels/Resorts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- HTHT Consumer Discretionary
- ASND Health Care
- Exchange
- HTHT Nasdaq
- ASND Nasdaq
- Market Cap
- HTHT N/A
- ASND 9.9B
- IPO Year
- HTHT 2010
- ASND 2015
- Fundamental
- Price
- HTHT $36.77
- ASND $154.68
- Analyst Decision
- HTHT Strong Buy
- ASND Strong Buy
- Analyst Count
- HTHT 3
- ASND 14
- Target Price
- HTHT $48.00
- ASND $201.79
- AVG Volume (30 Days)
- HTHT 2.1M
- ASND 432.7K
- Earning Date
- HTHT 03-20-2025
- ASND 05-01-2025
- Dividend Yield
- HTHT 4.30%
- ASND N/A
- EPS Growth
- HTHT N/A
- ASND N/A
- EPS
- HTHT 1.32
- ASND N/A
- Revenue
- HTHT $3,273,143,260.00
- ASND $376,478,932.00
- Revenue This Year
- HTHT $6.91
- ASND $58.89
- Revenue Next Year
- HTHT $7.96
- ASND $75.85
- P/E Ratio
- HTHT $27.96
- ASND N/A
- Revenue Growth
- HTHT 9.18
- ASND 36.34
- 52 Week Low
- HTHT $27.03
- ASND $111.09
- 52 Week High
- HTHT $42.98
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- HTHT 49.93
- ASND 50.46
- Support Level
- HTHT $37.19
- ASND $161.50
- Resistance Level
- HTHT $39.34
- ASND $161.91
- Average True Range (ATR)
- HTHT 1.22
- ASND 5.67
- MACD
- HTHT -0.16
- ASND -1.01
- Stochastic Oscillator
- HTHT 41.06
- ASND 55.21
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.